Thanks, Ethan for bringing Blue Prism to our attention. I looked at the financials last week and have since taken a 3% position. Being a UK listed company makes the analysis a little different. The company reports results every 6 months instead of every 3 months. The financials can be accessed from the Blue Prism invest relations website:
https://investors.blueprism.com/investors/results-centre
Blue Prism has all of the attributes of our hyper growth SaaS companies: blistering fast growth, high margins, recurring revenue. It looks like their OPEX as a percentage of revenue is now declining and they may be cashflow positive sometime next year. They also continue to grow their customer count and they continue to upsell their install base which is a testament to the value that customers derive from their service. The ROI achieved by their customers makes continued future customer adoption highly probable. When they mentioned the 10-15% hit to their business from COVID-19, I thought of AYX. I think that last period’s drop-off was likely a 1-2 period blip. I think the same is likely with AYX. When customers get such high ROIs, they will implement. I think customers will resume such implementations (for AYX too) as the initial chaos of the global shutdowns likely caused enterprises to pause while they put out fires and assessed the damage. AYX and Blue Prism might be similar in this regard. Since Blue Prism will next report results in late November or early December, we might look to AYX’s next results for clues about how Blue Prism’s results might look.
I would rather invest in the top company which is UiPath in the RPA space. However, Blue Prism seems to me to be a diamond in the rough. The EV/S is below 8 while companies with similar characteristics are trading at 3-4x (or more) higher multiples. When UiPath goes IPO, I would think that the multiple for that IPO would be well over 30x (all things being equal to today’s SaaS valuations). Seems to me that this would very likely pull Blue Prism’s multiple up significantly since Blue Prism’s multiple is so far below SaaS companies with comparable financial metrics…UiPath will give a direct comparable and such a large valuation discrepancy would not last long (IMO). In fact, at that time of a UiPath IPO, I might consider switching horses from Blue Prism to UiPath, but I’d like to ride up a company in the space in the meantime. We’ll see. For now, Blue Prism, while not perfect, is clearly the best bet in the RPA space.
There is always a chance for an acquisition. IBM and Microsoft have bought companies. Other tech giants like Oracle might be interested in getting into this rapidly growing market.
The shares are traded in London and that market provides more liquidity than buying in the US. The UK ticker is PRSM:GB and the US ticker is BPRMF. The UK shares trade at higher volume but even so that volume is not that great, and Blue Prism is barely over $1B market cap. Note: buying in the London exchange or in the US market results in the same shares (I bought PRSM:GB using my international trading team at my broker and after the purchase the shares in my account were coded BPRMF). I can speculate that if there is more interest from readers of this board that the shares might be driven up over the next few days. Be careful and use limit orders if you decide you want a position.
Chris